Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies
Hao Zhou, Belinda M. Dcosta, Marie I. Samanovic, et al.
mBio (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand, the human ACE2 receptor on binding affinity and kinetics
Michael I. Barton, Stuart A. MacGowan, Mikhail A. Kutuzov, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 333
A Comprehensive Review of COVID-19 Virology, Vaccines, Variants, and Therapeutics
Lauren Forchette, William Sebastian, Tuoen Liu
Current Medical Science (2021) Vol. 41, Iss. 6, pp. 1037-1051
Open Access | Times Cited: 224
Monoclonal antibody therapies against SARS-CoV-2
Daniele Focosi, Scott A. McConnell, Arturo Casadevall, et al.
The Lancet Infectious Diseases (2022) Vol. 22, Iss. 11, pp. e311-e326
Open Access | Times Cited: 204
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Vikram Thakur, Shivam Bhola, Pryanka Thakur, et al.
Infection (2021) Vol. 50, Iss. 2, pp. 309-325
Open Access | Times Cited: 167
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
Sindhu Ramesh, Manoj Govindarajulu, Rachel S. Parise, et al.
Vaccines (2021) Vol. 9, Iss. 10, pp. 1195-1195
Open Access | Times Cited: 131
SARS-CoV-2: Evolution and Emergence of New Viral Variants
Verónica Roxana Flores-Vega, Jessica Viridiana Monroy-Molina, Luis Enrique Jiménez-Hernández, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 653-653
Open Access | Times Cited: 85
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant
Hao Zhou, Michelle Møhlenberg, Jigarji Chaturji Thakor, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 3
Open Access | Times Cited: 67
Casirivimab/Imdevimab: First Approval
Emma D. Deeks
Drugs (2021) Vol. 81, Iss. 17, pp. 2047-2055
Open Access | Times Cited: 83
Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice
Kaichun Wu, Angela Choi, Matthew Koch, et al.
Vaccine (2021) Vol. 39, Iss. 51, pp. 7394-7400
Open Access | Times Cited: 83
Structural Evaluation of the Spike Glycoprotein Variants on SARS-CoV-2 Transmission and Immune Evasion
Mohd Zulkifli Salleh, Jeremy P. Derrick, Zakuan Zainy Deris
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7425-7425
Open Access | Times Cited: 78
Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies
Maryam Noori, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 73
Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
Ting Pan, Ran Chen, Xin He, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 71
Emerging SARS-CoV-2 Variants: Genetic Variability and Clinical Implications
Aakriti Dubey, Shweta Choudhary, Pravindra Kumar, et al.
Current Microbiology (2021) Vol. 79, Iss. 1
Open Access | Times Cited: 71
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective
Sarah Halawa, Soni Savai Pullamsetti, Charles R. M. Bangham, et al.
Nature Reviews Cardiology (2021) Vol. 19, Iss. 5, pp. 314-331
Open Access | Times Cited: 71
mRNA-1273 protects against SARS-CoV-2 beta infection in nonhuman primates
Kizzmekia S. Corbett, Anne P. Werner, Sarah O’ Connell, et al.
Nature Immunology (2021) Vol. 22, Iss. 10, pp. 1306-1315
Open Access | Times Cited: 63
A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice
Tianyang Mao, Benjamin Israelow, Carolina Lucas, et al.
The Journal of Experimental Medicine (2021) Vol. 219, Iss. 1
Open Access | Times Cited: 61
Genomic analysis reveals a rapid spread and predominance of lambda (C.37) SARS‐COV‐2 lineage in Peru despite circulation of variants of concern
Carlos Padilla, Víctor Jimenez‐Vasquez, Verónica Hurtado, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6845-6849
Open Access | Times Cited: 58
Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
Fuxing Lou, Maochen Li, Zehan Pang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 55
COVID‐19: A systematic review and update on prevention, diagnosis, and treatment
Hooman Aghamirza Moghim Aliabadi, Reza Eivazzadeh‐Keihan, Arezoo Beig Parikhani, et al.
MedComm (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 43
Regional and temporal coordinated mutation patterns in SARS-CoV-2 spike protein revealed by a clustering and network analysis
Surendra S. Negi, Catherine H. Schein, Werner Braun
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 39
SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants
Dima Hattab, Mumen F. A. Amer, Zina M. Al‐Alami, et al.
Infection (2024) Vol. 52, Iss. 3, pp. 767-786
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top